Kristen Pratt Machado is executive editor for Dimensions of Dental Hygiene and Decisions in Dentistry and director of publishing operations for Belmont Business Media. She has been with the company since its inception in 2001.
This information is from the article Reduce Aerosol Risk With Preprocedural Mouthrinse By Rosette Bravo-Nguyen, RDH, BA. To read the article, click here.
During the week of February 1, the United States experienced a 25% decrease in new COVID-19 cases and a 15% reduction in the number of patients hospitalized due to COVID-19 illness. These significant drops follow 4 weeks of declines in new…
Dental hygienists advocate and promote oral health for their patients and recognize the systemic effects of periodontal diseases. Dental hygienists can also assist their patients by promoting the oral health of their pets. Pet owners need…
As it is estimated that at least 75% of Americans need to be vaccinated against SARS-CoV-2 in order to achieve herd immunity, the race is on to see which states can vaccinate their residents the quickest. Globally, Israel—with a population…
Developed in the United Kingdom, the COVID-19 vaccine from AstraZeneca and the University of Oxford has shown 74.6% effectiveness against the new, more contagious UK-based variant, B117, of SARS-CoV-2. The research results were published…
Johnson & Johnson (J&J) has applied for an Emergency Use Authorization (EUA) from the United States Food and Drug Administration (FDA) for its one-shot COVID-19 vaccine, which has shown 66% efficacy in preventing moderate to severe…
As efforts to improve COVID-19 vaccination rates ramp up, more states are allowing oral health professionals to administer these immunizations after completing a certain amount of training. Currently, specially trained dental hygienists are…
It has been a year since the United States declared a public health emergency because of the rapid transmission of SARS-CoV-2. The US issued this declaration on February 3, 2020, three days following a similar statement made by the World…
A peer-reviewed study in the highly regarded journal The Lancet found that Sputnik V, a new COVID-19 vaccine developed in Russia, was 91.6% effective in preventing infection with the novel coronavirus. The study included 22,000 subjects and…
The United States Department of Defense has entered into a $231 million agreement with the Australian company, Ellume, to fund the manufacture of its rapid and inexpensive COVID-19 test. Available without a prescription, the COVID-19 test…